Literature DB >> 24524778

Chinese patients' satisfaction with total hip arthroplasty: what is important and dissatisfactory?

Hao Tang1, Hui Du1, Qiheng Tang1, Dejin Yang1, Hongyi Shao1, Yixin Zhou1.   

Abstract

Through validated self-administered questionnaires, we conducted a retrospective investigation in 818 patients (1009 hips) who underwent primary THA, to collect data on overall satisfaction plus satisfaction and importance rating for 16 specific functions and issues. Overall, 8.1% patients were dissatisfied with the surgery. The top 3 important items are pain relief, squatting, and walking. The top 3 dissatisfactory items are jogging, squatting, and rising after squatting. The strongest risk factors for dissatisfaction with walking were pain (6.1×), muscle weakness(3.7×), and LLD (3.3×). The strongest risk factors for dissatisfaction with squatting were low postoperative HHS ROM (3.7×) and muscle weakness (2.6×). For Chinese patients, ROM, muscle strength and LLD are very important.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Importance; Satisfaction; Total hip arthroplasty

Mesh:

Year:  2014        PMID: 24524778     DOI: 10.1016/j.arth.2013.12.032

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  11 in total

1.  Cultural Factors Influencing Osteoarthritis Care in Asian Communities: A Review of the Evidence.

Authors:  Thrmiga Sathiyamoorthy; Shabana Amanda Ali; Marita Kloseck
Journal:  J Community Health       Date:  2018-08

2.  [Long-term effectiveness of total hip arthroplasty for Crowe type developmental dysplasia of the hip].

Authors:  Yixin Zhou; Yong Huang; Ruizhe He; Yaming Chu; Jianming Gu; Hua Li; Ning Ma
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-12-15

3.  Single-item satisfaction scores mask large variations in pain, function and joint awareness in patients following total joint arthroplasty.

Authors:  F L Loth; J M Giesinger; K Giesinger; C R Howie; D F Hamilton
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-12-09

Review 4.  [Perioperative pain management of total hip arthroplasty].

Authors:  Qiang Xiao; Zongke Zhou
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2019-09-15

5.  Comparison of cylindrical and tapered stem designs for femoral revision hip arthroplasty.

Authors:  Yu Zhang; Ye Zhang; Jian-Ning Sun; Zi-Jian Hua; Xiang-Yang Chen; Shuo Feng
Journal:  BMC Musculoskelet Disord       Date:  2020-06-29       Impact factor: 2.362

6.  Dynamic hip kinematics during squatting before and after total hip arthroplasty.

Authors:  Keisuke Komiyama; Satoshi Hamai; Daisuke Hara; Satoru Ikebe; Hidehiko Higaki; Kensei Yoshimoto; Kyohei Shiomoto; Hirotaka Gondo; Yifeng Wang; Yasuharu Nakashima
Journal:  J Orthop Surg Res       Date:  2018-07-03       Impact factor: 2.359

7.  Prospective randomized controlled study on improving sleep quality and impact of zolpidem after total hip arthroplasty.

Authors:  Hirose Shakya; Duan Wang; Kai Zhou; Ze-Yu Luo; Suraj Dahal; Zong-Ke Zhou
Journal:  J Orthop Surg Res       Date:  2019-09-03       Impact factor: 2.359

8.  A new 3D printing porous trabecular titanium metal acetabular cup for primary total hip arthroplasty: a minimum 2-year follow-up of 92 consecutive patients.

Authors:  Xiao Geng; Yang Li; Feng Li; Xinguang Wang; Ke Zhang; Zhongjun Liu; Hua Tian
Journal:  J Orthop Surg Res       Date:  2020-09-04       Impact factor: 2.359

9.  Analgesic effect of single-shot ropivacaine at different layers of the surgical site in primary total hip arthroplasty: a randomised, controlled, observer-blinded study.

Authors:  Qiang Xiao; Bing Xu; Haoyang Wang; Zhenyu Luo; Mingcheng Yuan; Zongke Zhou; Fuxing Pei
Journal:  J Orthop Surg Res       Date:  2021-01-22       Impact factor: 2.359

10.  Clinical and Radiological Outcomes of Revision Total Hip Arthroplasty for Patients with Prior Hartofilakidis Type C Hip Dysplasia.

Authors:  Shengjie Guo; Hao Tang; Zhuyi Ma; Yong Huang; Yixin Zhou
Journal:  Orthop Surg       Date:  2022-09-03       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.